ADC Therapeutics SA

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 70
EBIT TTM (mln): -115
index 0 1 2 3 4 5 6 7
Rok finansowy 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 2 1 2 0 34 210 70 69
Przychód Δ r/r 0.0% -36.8% 105.3% -100.0% inf% 518.9% -66.9% -0.4%
Marża brutto 100.0% 100.0% -4495.6% -inf% 95.9% 97.8% 96.4% 91.4%
EBIT (mln) -92 -126 -119 -219 -262 -124 -166 -131
EBIT Δ r/r 0.0% 37.4% -5.2% 83.6% 19.4% -52.8% 34.3% -21.3%
EBIT (%) -5084.3% -11047.5% -5102.5% 0.0% -771.6% -58.9% -238.6% -188.6%
Koszty finansowe (mln) -3 -3 0 5 18 37 46 50
EBITDA (mln) -92 -125 -114 -238 -233 -99 -146 -103
EBITDA(%) -5111.1% -11001.2% -4865.2% 0.0% -687.5% -47.1% -209.6% -148.2%
Podatek (mln) 0 0 1 0 -21 1 39 0
Zysk Netto (mln) -90 -123 -116 -246 -230 -156 -240 -158
Zysk netto Δ r/r 0.0% 37.0% -5.4% 111.4% -6.6% -32.3% 54.1% -34.2%
Zysk netto (%) -4984.0% -10797.9% -4977.9% 0.0% -678.2% -74.2% -345.1% -227.8%
EPS -1.53 -2.29 -1.74 -3.77 -3.0 -1.99 -2.94 -1.62
EPS (rozwodnione) -1.53 -2.29 -1.74 -3.77 -3.0 -1.99 -2.94 -1.62
Ilośc akcji (mln) 59 54 67 65 77 78 82 97
Ważona ilośc akcji (mln) 59 54 67 65 77 78 82 97
Waluta USD USD USD USD USD USD USD USD